Iloprost showed a highly significant reduction in the level of pain evaluated by VAS during intravenous application within five days starting from 5.3 (sd = 2.0; range = 2 to 10) before treatment (day 0) to 2.5 (sd = 1.7; range = 0 to 6) on average at day five.
← all excerpts
Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.
1
—
—